Search results for " 2016"
Article
Digitalization: The Route to Biopharma 4.0
In 2015 12th International Conference on Fuzzy Systems and Knowledge Discovery (FSKD); Zhangjiajie: IEEE; 2016. DOI: 10.1109/FSKD.2015.7382284
2. Knevelman, C.; Davies, J.; Allen, L.; et al. Hig…
Article
Reimagining Affordable Biosimilars
Advances in preclinical development play a crucial role in reducing cost for developing biosimilars.
By Anurag S. Rathore, Narendra Chirmule, and Himanshu Malani
Drug development is …
Article
Eliminating Residual Impurities Starts with a Strategic Plan
Eliminating Residual Impurities Starts with a Strategic Plan
Identifying the source, assessing the risk, and removing residual impurities requires a strategic approach.
By Cynthia A. Ch…
Article
Biomanufacturing: Demand for Continuous Bioprocessing Increasing
This is up from 68% based on data from our 2016 Annual Report (1).
According to BioPlan’s 17th Annual Report and Survey on Biopharmaceutical Manufacturing Capacity and Production (2), there has…
Article
Maximizing the Effectiveness of Upstream Bioprocessing Through the Combination of Lab Informatics and Instrumentation
First published in 2016, the four foundational FAIR principles apply to both human-driven and machine-driven activities and are particularly important for advanced analytics, such as artificial intell…
Article
Single-Use for Downstream Chromatography: Benefit or Hindrance?
Single-use technology is gaining ground in downstream bioprocessing, but challenges stall further adoption.
By Feliza Mirasol
ARTMOIS/STOCK.ADOBE.COM
Biopharmaceutical manufactu…
Article
Real-Time Characterization of Biotherapeutics and Comparability of Biosimilars
Real-Time Characterization of Biotherapeutics and Comparability of Biosimilars
A major advantage of SPR-based analysis is its ability to estimate the association and dissociation rate constants, an …
Article
Ensuring Viral Safety of Viral Vaccines and Vectors
EMA, Guideline on Influenza Vaccines(London, July, 2016).
15. EMA, Guideline on Quality, Non-Clinical & Clinical Aspects of Live Recombinant Viral Vectored Vaccines(London, June , 2010).
1…
Article
Automation Trend in Fill/Finish Reduces Contamination Risk
Langer, Pharmaceutical Technology 40 (10) 2016.
4. R. Hernandez, BioPharm International 29 (9) 2016.
5. ABL, Inc., “ABL Increases Aseptic Fill/Finish Capacity with State-of-the-Art, Fully Automa…
Article
Industry Adoption of Single-Use Systems Remains Low
Additionally, in 2016, the company announced a $7-million expansion project in Westborough, MA (5), where a range of single-use products, including cell growth bags, will be manufactured. Other recent…